<DOC>
	<DOCNO>NCT00469326</DOCNO>
	<brief_summary>This study investigate potential protective effect atorvastatin pre-treatment patient stable coronary artery disease undergo percutaneous coronary intervention ( PCI ) . Patient randomize two group : atorvastatin pre-treatment group ( 80mg atorvastatin two day PCI ) control group ( PCI without atorvastatin pretreatment ) . Endpoint myocardial infarction measure troponin I creatine kinase myocardial band .</brief_summary>
	<brief_title>Atorvastatin Pre-Treatment Influences Risk Percutaneous Coronary Intervention Study</brief_title>
	<detailed_description>Randomized study show pre-treatment atorvastatin may reduce periprocedural myocardial patient stable angina elective PCI . These data provide evidence-based support use atorvastatin 7 day PCI ( dosage 40mg/d ) , alternatively three day ( unknown dosage ) . We want confirm result short pre-treatment period ( two day ) dosage 80mg per day .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>stable angina last month indication percutaneous coronary intervention inform consent acute coronary syndrome last 14 day renal insufficiency ( creatinine 150 Âµmol/l ) diseases severely limiting prognosis immunosuppressive treatment statin one month randomization occlusion coronary artery previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>atorvastatin</keyword>
</DOC>